Lonza slashes 500 jobs in Switzerland; Patheon inks manufacturing deal;

> CRO Pacific BioLabs has acquired Bay Bioanalytical Laboratory, folding analytical and bioanalytical chemistry into its in vivo preclinical and microbiological testing services. More

> Cytovance Biologics has inked a development and manufacturing deal with Fountain BioPharma for FB301, a novel monoclonal antibody. News

> Patheon ($PTI) has signed on with Pharmalink to manufacture the company's Nefecon treatment for nephropathy, which can lead to renal disease. Article

> Lonza is cutting 500 jobs at its API plant in Switzerland. Story

> Outsourcing-Pharma checked in with a few East Coast-based CMOs, all of which reported only minor damages from last week's hurricane. Report

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.